These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1593577)

  • 1. Lupus anticoagulant: correlation with magnetic resonance imaging of brain lesions.
    Molad Y; Sidi Y; Gornish M; Lerner M; Pinkhas J; Weinberger A
    J Rheumatol; 1992 Apr; 19(4):556-61. PubMed ID: 1593577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus.
    Brooks WM; Sabet A; Sibbitt WL; Barker PB; van Zijl PC; Duyn JH; Moonen CT
    J Rheumatol; 1997 Dec; 24(12):2323-9. PubMed ID: 9415636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of systemic lupus erythematosus (SLE) involving the central nervous system by magnetic resonance imaging (MRI)].
    Suzuki K; Hara M; Nakajima S; Hirose T; Kitani A; Norioka K; Harigai M; Kawakami M; Tabata H; Kawagoe M
    Ryumachi; 1989 Apr; 29(2):88-96. PubMed ID: 2772757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension.
    Csépány T; Bereczki D; Kollár J; Sikula J; Kiss E; Csiba L
    J Neurol; 2003 Nov; 250(11):1348-54. PubMed ID: 14648152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies.
    Hachulla E; Michon-Pasturel U; Leys D; Pruvo JP; Queyrel V; Masy E; Arvieux J; Caron C; Brevet-Coupé F; Hatron PY; Devulder B
    Lupus; 1998; 7(2):124-31. PubMed ID: 9541097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
    Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
    Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
    Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
    J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolism complicating the treatment of lupus anticoagulant hypoprothrombinemia syndrome.
    Vinet E; Rich E; Senécal JL
    J Rheumatol; 2006 Oct; 33(10):2088-90. PubMed ID: 16924686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Magnetic resonance imaging and lupus erythematosus of the nervous system].
    Schott AM; Colson F; Tebib J; Noël E; Bouvier M
    Rev Rhum Mal Osteoartic; 1990 Nov; 57(11):785-90. PubMed ID: 2291069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance imaging in lupic chorea].
    Forrett-Kaminsky MC; Scherer C; Kaminsky P; Klein M; Duc M
    Rev Neurol (Paris); 1992; 148(5):383-4. PubMed ID: 1448657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody.
    Ishikawa O; Ohnishi K; Miyachi Y; Ishizaka H
    J Rheumatol; 1994 Jan; 21(1):87-90. PubMed ID: 8151596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal findings of magnetic resonance imaging (MRI) in patients with systemic lupus erythematosus involving the brain].
    Ishikawa A; Okada J; Kondo H; Kashiwazaki S
    Ryumachi; 1992 Jun; 32(3):191-9. PubMed ID: 1523521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The incidence of the antiphospholipid syndrome in the clinical and biological manifestations of systemic lupus erythematosus].
    Sánchez Rodríguez A; Martín Oterino JA; Fidalgo Fernández MA; Araoz Sánchez P; Alonso García P; Fernández Navarro P; Chimpén Ruiz V; Portugal Alvarez J
    Rev Clin Esp; 1997 Oct; 197(10):669-74. PubMed ID: 9424663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.